An automated cell culture market system automates the process of developing, increasing, and sustaining cell cultures, which formerly involved a large amount of manual labour. These systems have increased in popularity as a result of their potential to save money, time, and increase sample consistency and efficiency, which were previously faulty in manual systems. The pharmaceutical and biotechnology companies sector dominated the automated cell culture revenue share in 2019, accounting for approximately 37.8% of the market share, and is expected to grow significantly through 2027.